• Create and ensure execution of the insights generation plan that helps inform Bei Gene understanding of unmet needs, likely evolution in the standard of care, and key stakeholder requirements to drive adoption of emerging therapies.
• In partnership with the Business Insights (CBDI) team, ensure a comprehensive understanding of the relevant patient segments, marketplace events, and industry pipeline in Lung Cancer. Present key updates as needed to Project and Executive teams.
• In close coordination with Early Development Teams and the Disease Area Strategy team, ensure a comprehensive set of TPPs are developed and maintained. As a best practice, the TPPs will be based upon deep customer and competitive insights which guide the development of differentiated assets.
• In partnership with Portfolio Strategy & Valuation (PS&V) colleagues, advance efforts to quantify the commercial potential of target patient populations as identified within the TPPs, and ensure full evidence requirements to secure global reimbursement are captured within the TPP and asset development plans.
• Represent ONE commercial voice to Early Development Teams (EDTs), including the priority Pan KRASi and PRMT5 programs. Coordinate with other commercial stakeholders to ensure an integrated, global commercial perspective is included in early asset development decisions.
• Help relevant functional partners maintain pipeline valuation metrics for the Lung Cancer portfolio, ensuring any investment decisions are supported by robust commercial assessments and balance Bei Gene priorities on risk / return considerations, and speed to the marketplace.
• Collaborate with cross-regional, and cross-functional team members to shape disease area strategies for multiple indications.
• As required, guide commercial decisions regarding early asset positioning, messaging, and branding considerations prior to the formation of Global Product Teams (GPTs).
• In close coordination with cross-functional team members such as Medical Affairs and Corporate Affairs, identify partnership opportunities with Lung Cancer patient organizations and define/execute tactics aligned to the shared agenda of disease education and improving access to efficacious therapies around the globe.
• Lead cross-functional collaboration to ensure alignment of global commercial strategies within the DAS, including members from R&D, medical affairs, market access and major market organizations.
• Partner with Tech Ops to address any capacity planning considerations.
• Maintain strong relationships with both internal colleagues and external customers to address market opportunities.
• The priority for this role is the Lung Cancer space and associated early development programs. As business needs warrant, this role may provide support to another Disease Area / EDT as the Bei Gene portfolio evolves.

• 10+ years of experience in pharmaceutical marketing/healthcare-related commercial experience.
• Must have 3+ years of Global Marketing/New Product Planning expertise.
• Previous experience working in Lung Cancer, either at a global level or in-market brand leadership roles. Demonstrated fluency in the current standard-of-care by key Lung Cancer patient segments and emerging modalities within the industry pipeline.
• Demonstrated experience in leading brand strategy/new product planning at various stages of lifecycle.
• Strong team player who can incorporate input from key stakeholders (both internally and externally) and drive cross-regional and cross-functional alignment.
• Detailed understanding of opportunity assessment and valuation methodologies deployed within the pharmaceutical industry.
• Proven ability to inspire, motivate and lead matrixed teams.
• Highly skilled and effective in engaging, connecting, and influencing across all levels from senior leadership to local marketing teams.
• Understanding of change management principles and experience driving change across an organization.
• Strong ability and desire to work across time zones, geographies, and cultures to improve the lives of patients and caregivers.

• 12+ years of experience in pharmaceutical marketing/healthcare-related commercial experience.
• Demonstrated track record of leading early asset / New Product Planning teams through key R&D milestones (e.g Po C, C2P3, C2F).
• Commercial forecasting and/or financial modeling experience.

• Consistent with other Global Commercial Strategy & Operations roles, this position will be home-office based. Preferential consideration for candidates based in USA or Switzerland.

• This position will not be responsible for management of direct reports. However, it will require significant cross-functional team leadership and direction of third-party agencies.

• Fosters Teamwork
• Provides and Solicits Honest and Actionable Feedback
• Self-Awareness
• Acts Inclusively
• Demonstrates Initiative
• Entrepreneurial Mindset
• Continuous Learning
• Embraces Change
• Results-Oriented
• Analytical Thinking/Data Analysis
• Financial Excellence
• Communicates with Clarity